Will Semaglutide Prevent Heart Attacks, Strokes & Cravings?
, buOzempic for diabetes and Wegovy for weight loss are now familiar brand names for the pharmaceutical compound…
Pills that communicate from the stomach could improve medication adherence | MIT News
In an advance that could help ensure people are taking their medication on schedule, MIT engineers have designed…
Midwest Chiropractic celebrates new home
Midwest Chiropractic celebrated the opening of their new Iola location Wednesday afternoon, exactly 39 years after they first…
Health Minister ‘committed’ to listing weight-loss drugs on PBS
Australian doctors are pushing to add weight-loss drugs to the Pharmaceutical Benefits Scheme (PBS) in a move that…
Trump takes higher-than-recommended aspirin: How much dosage is safe and the risks of taking too much
US President Donald Trump’s health has once again come under scrutiny after he revealed that he takes a…
Is It Healthy to Take Aspirin Every Day? – The New York Times
Is It Healthy to Take Aspirin Every Day? The New York TimesTrump’s health issue is growing. Maybe it’s JD…
High-cost drugs set for price cuts – Australian Journal of Pharmacy
High-cost drugs set for price cuts Australian Journal of PharmacyCheaper medicines for children’s inflammatory diseases, rare liver disease and…
Govt approves several ordinances, guidelines on essential drugs
Govt approves several ordinances, guidelines on essential drugs Chief Adviser Professor Professor Muhammad Yunus presided over the Council…
Pharmacists issue seven-day warning to millions who use popular cold and flu medicine
Nasal decongestant spray can be used to treat blocked noses – but users could face their symptoms getting…
Popular weight loss drugs face new scrutiny over rare brain risk
Weight loss and diabetes drugs from the GLP-1 family, including Ozempic, Wegovy and Mounjaro, have emerged as a…
FDA approves first pill for weight loss: 5 things to know
Share on PinterestThe FDA has approved the first GLP-1 pill for weight loss. Bloomberg Creative/Getty ImagesIn December 2025,…
Vanda Pharmaceuticals Announces Receipt of FDA Decision Letter on HETLIOZ® Supplemental New Drug Application for Jet Lag Disorder
WASHINGTON, Jan. 8, 2026 /PRNewswire/ — Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that it has received…